Bayer headlined its second-quarter results this morning by unveiling a deal to buy Vividion Therapeutics, saying it will boost its ability to develop medicines against targets once considered ...
Roche’s Genentech unit signed a trio of deals this week to add new drug discovery platforms to its repertoire. The three drug discovery deals are with Convelo Therapeutics in neurological disorders ...
Microsoft said my PC can't run Windows 11, but I upgraded in 5 minutes anyway - here's how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results